- 1401. Institute of Medicine
- [As part of the National Academy of Science, identifies, for study and analysis, important issues and problems that relate to health and medicine. The Institute initiates and conducts studies of national policy and planning for health care and health-related education and research; it also responds to requests from the federal government and other agencies for studies and advice. ( NCI )] (UMLS (NCI) C0021621) =Health Care Related Organization
| - 1451. insulin resistance
- [Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. It can be caused by the presence of INSULIN ANTIBODIES or the abnormalities in insulin receptors (RECEPTOR, INSULIN) on target cell surfaces. It is often associated with OBESITY; DIABETIC KETOACIDOSIS; INFECTION; and certain rare conditions. (from Stedman, 25th ed) ( MSH )] (UMLS (CSP) C0021655) =Pathologic Function
|
- 1402. Instituted Ongoing Monitoring Program
- [Arranged to monitor patient for adverse effects ( HL7V3.0 )] (UMLS (HL7) C1555296) =Health Care Activity =Other Action Taken;
| - 1452. insulin secretion
- [The regulated release of proinsulin from secretory granules (B granules) in the B cells of the pancreas; accompanied by cleavage of proinsulin to form mature insulin. [GOC:mah, ISBN:0198506732 "Oxford Dictionary of Biochemistry and Molecular Biology"] ( GO )] (UMLS (CSP) C1256369) =Cell Function ;
|
- 1403. Institution
- [Institution ( HL7V3.0 )] (UMLS (HL7) C1546848) =Idea or Concept =Living Arrangement;
LivingArrangement =Group Home;
nursing home;
Extended care facility;
Retirement Community | - 1453. insulin sensitivity
- [ ] (UMLS (CSP) C0920563) =Pathologic Function
|
- 1404. Institution bills for provider
- (UMLS (HL7) C1549622) =Idea or Concept =Provider billing;
| - 1454. insulin sensitivity/resistance
- [diminished effectiveness of insulin in raising or lowering blood sugar levels; it is associated with obesity, diabetes mellitus, ketoacidosis, infection, and certain rare conditions. ( CSP )] (UMLS (CSP) C0678154) =Pathologic Function ;
=drug resistance;
drug tolerance;
hormone sensitivity/resistance;
=metabolic syndrome;
|
- 1405. Institution Relationship Type
- (UMLS (HL7) C1547909) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Contractor;
Consultant;
Employee;
Volunteer;
| - 1455. insulin tolerance
- [ ] (UMLS (CSP) C0598703) =Pathologic Function ;
|
- 1406. institutional care facility
- [facility which fosters the care of individuals who are in need of housing and daily care, such as orphans, foundlings, abandoned children, and homeless; also for adult day care facilities; not for the care of ill or those of in need of rehabilitation for this concept see HEALTH CARE FACILITY or its narrower terms. ( CSP )] (UMLS (CSP) C0596782) =Manufactured Object; Health Care Related Organization =social service;
| - 1456. Insulin Zinc Injectable Suspension
- [A long-acting form of crystalline insulin often used in combination with a short-acting insulin in the treatment of diabetes mellitus. Administered once daily, this type of insulin may be derived from porcine, bovine, or recombinant sources. Endogenous human insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats; it has anabolic effects on many types of tissues. (NCI04) ( NCI )] (UMLS (NCI) C0041616) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 1407. institutional financing
- [ ] (UMLS (CSP) C0596783) =Governmental or Regulatory Activity ;
| - 1457. Insulin, Lente
- [A long-acting crystalline insulin often used in combination with a short-acting insulin in the treatment of diabetes mellitus. This type of insulin may be derived from porcine or recombinant sources. Administered once daily, insulin Lente starts to lower blood glucose within 1 to 3 hours after injection and exerts its peak effect 7 to 15 hours after injection. Endogenous human insulin, a pancreatic hormone composed of two polypeptide chains, is important for the normal metabolism of carbohydrates, proteins and fats; it has anabolic effects on many types of tissues. (NCI04) ( NCI )] (UMLS (NCI) C0021659) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 1408. Institutional Review Board
- [A group of scientists, doctors, clergy, and consumers at each health care facility that participates in a clinical trial. IRBs are designed to protect study participants. They review and must approve the action plan for every clinical trial. They check to see that the trial is well designed, does not involve undue risks, and includes safeguards for patients. ( NCI )] (UMLS (NCI) C0086911) =Professional or Occupational Group ;
| - 1458. Insulin, NPH
- [An intermediate-acting insulin used in the treatment of diabetes mellitus. Administered once or twice daily, NPH (neutral protamine hagedorn) insulin lowers blood glucose within 1 to 2 hours after administration and exerts a peak effect at 6 to 10 hours. Endogenous insulin, a pancreatic hormone composed of two polypeptide chains, is important in the normal metabolism of carbohydrates, proteins and fats, promoting glucose utilization and protein synthesis; it has anabolic effects on many types of tissues. (NCI04) ( NCI )] (UMLS (NCI) C0021658) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 1409. INSTRMNT FAIL IN SURGERY
- [ ] (UMLS (ICD9CM) C0261554) =Injury or Poisoning
| - 1459. insulinlike factor
- [ ] (UMLS (CSP) C0596784) =Pharmacologic Substance ;
=antihyperglycemic;
|
- 1410. INSTRMNT FAIL-CATHETERIZ
- [ ] (UMLS (ICD9CM) C0261558) =Injury or Poisoning
| - 1460. insulinotropin
- [ ] (UMLS (CSP) C0063686) =Amino Acid, Peptide, or Protein
|
- 1411. INSTRMNT FAIL-HEART CATH
- [ ] (UMLS (ICD9CM) C0261559) =Injury or Poisoning
| - 1461. Insurance
- [A mechanism for guarding against financial aspects of risk by making payments in the form of premiums to an insurance company, which pays an agreed-upon sum to the insured in the event of loss. ( NCI )] (UMLS (NCI) C0021672) =Idea or Concept
|
- 1412. INSTRMNT FAIL-PERFUS NEC
- [ ] (UMLS (ICD9CM) C0261556) =Human-caused Phenomenon or Process
| - 1462. insurance (nonhealth)
- [ ] (UMLS (CSP) C0599809) =Idea or Concept ;
|
- 1413. INSTRMNT FAIL-PROCED NEC
- [ ] (UMLS (ICD9CM) C0261560) =Phenomenon or Process
| - 1463. Insurance certification definition
- (UMLS (HL7) C1547362) =Idea or Concept =Data type;
|
- 1414. INSTRMNT FAIL-PROCED NOS
- [ ] (UMLS (ICD9CM) C0261561) =Phenomenon or Process
| - 1464. Insurance Company
- (UMLS (HL7) C1549448) =Idea or Concept =Contact Role;
Mail Claim Party;
Eligibility Source;
|
- 1415. Instruction
- [A message describing how something is to be done. ( NCI )] (UMLS (NCI) C0302828) =Intellectual Product
| - 1465. Insurance Company Contact Reason
- (UMLS (HL7) C1547638) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Medicare claim status;
Medicaid claim status;
Name/address change |
- 1416. instructor
- [ ] (UMLS (CSP) C0556993) =Professional or Occupational Group
| - 1466. Insurance company ID codes
- (UMLS (HL7) C1547687) =Intellectual Product =HL7 Vocabulary Version 2.5;
|
- 1417. Instrument
- [Any object, or item of electrical or electronic equipment, which is designed to carry out a specific function or set of functions. ( NCI )] (UMLS (NCI) C0348000) =Medical Device
| - 1467. Insurance Plan ID
- (UMLS (HL7) C1550362) =Intellectual Product =HL7 Vocabulary Version 2.5;
|
- 1418. INSTRUMENT DELIVERY NEC
- [ ] (UMLS (ICD9CM) C0177271) =Therapeutic or Preventive Procedure
| - 1468. Insurance, Health, Reimbursement
- [Payment by a third-party payer in a sum equal to the amount expended by a health care provider or facility for health services rendered to an insured or program beneficiary. (From Facts on File Dictionary of Health Care Management, 1988) ( MSH )] (UMLS (NCI) C0021684) =Health Care Activity
|
- 1419. INSTRUMENT DELIVERY NOS
- [ ] (UMLS (ICD9CM) C0162209) =Therapeutic or Preventive Procedure ;
| - 1469. Insured
- (UMLS (HL7) C1548605) =Intellectual Product =Disabled Person Code;
|
- 1420. instrumental conditioning
- [modification of behavior by reinforcement (positive or negative) following some spontaneous behavior such as pressing a bar. ( CSP )] (UMLS (CSP) C0009651) =Mental Process ;
=Conditioned;
| - 1470. Insured presented card
- (UMLS (HL7) C1549469) =Idea or Concept =Eligibility Source;
|
- 1421. instrumentation
- [ ] (UMLS (CSP) C1704339) =Quantitative Concept ;
| - 1471. Insured presented policy
- (UMLS (HL7) C1549468) =Idea or Concept =Eligibility Source;
|
- 1422. INSTRUMNT FAIL-ENDOSCOPY
- [ ] (UMLS (ICD9CM) C0261557) =Injury or Poisoning
| - 1472. INT ASTHMA W (AC) EXAC
- (UMLS (ICD9CM) C1176340) Intrinsic asthma with acute exacerbation =Disease or Syndrome ;
|
- 1423. INSTRUMNT FAIL-INFUSION
- [ ] (UMLS (ICD9CM) C0261555) =Phenomenon or Process
| - 1473. INT ASTHMA W STATUS ASTH
- [ ] (UMLS (ICD9CM) C0155882) =Disease or Syndrome
|
- 1424. INSUF INTEROCCLUSL-TEETH
- [ ] (UMLS (ICD9CM) C1456197) Insufficient interocclusal distance of teeth (ridge);
=Disease or Syndrome | - 1474. INT DERANGEMENT KNEE NEC
- [ ] (UMLS (ICD9CM) C0158065) =Anatomical Abnormality
|
- 1425. INSUFF ANTERIOR GUIDANCE
- [ ] (UMLS (ICD9CM) C1291056) Insufficient anterior guidance;
=Anatomical Abnormality ;
| - 1475. INT DERANGEMENT KNEE NOS
- [ ] (UMLS (ICD9CM) C0158053) =Anatomical Abnormality
|
- 1426. Insufficiency, mitral
- [backflow of blood from the left ventricle into the left atrium, owing to imperfect functioning of the mitral valve. ( CSP )] (UMLS (NCI) C0026266) =Disease or Syndrome ;
=Heart Valve Diseases;
Insufficiency, Valvular | - 1476. INT DRAIN PANCREAT CYST
- [ ] (UMLS (ICD9CM) C0193599) =Therapeutic or Preventive Procedure
|
- 1427. Insufficiency, pulmonary
- [The backflow of blood from the pulmonary artery into the right ventricle, owing to insufficiency of the pulmonic semilunar valve. ( NCI )] (UMLS (NCI) C0034088) =Pathologic Function =Heart Valve Diseases;
| - 1477. INT FIX W/O FX REDUC NOS
- [ ] (UMLS (ICD9CM) C0376056) =Therapeutic or Preventive Procedure
|
- 1428. Insufficiency, tricuspid
- [The backflow of blood from the right ventricle into the right atrium, owning to imperfect functioning/insufficiency of the tricuspid valve. ( NCI )] (UMLS (NCI) C0040961) =Disease or Syndrome =Heart Valve Diseases;
| - 1478. INT FIX-NO FX REDUCT NEC
- [ ] (UMLS (ICD9CM) C0177418) =Therapeutic or Preventive Procedure
|
- 1429. Insufficiency, Valvular
- [Dysfunction of one of the cardiac valves, with incomplete valve closure resulting in valvular regurgitation. ( NCI )] (UMLS (NCI) C0042300) =Pathologic Function =Heart Valve Diseases;
=Aortic Insufficiency;
Insufficiency, mitral;
| - 1479. INT FIXATION-CHEST CAGE
- [ ] (UMLS (ICD9CM) C0177417) =Therapeutic or Preventive Procedure
|
- 1430. Insufficient authorization
- [The requesting party has insufficient authorization to invoke the interaction. ( HL7V3.0 )] (UMLS (HL7) C1552624) =Intellectual Product =ActAdministrativeAuthorizationDetectedIssueCode;
| - 1480. INT FIXATION-HUMERUS
- [ ] (UMLS (ICD9CM) C0186771) =Therapeutic or Preventive Procedure
|
- 1431. Insufficient services on day of partial hospitalization
- (UMLS (HL7) C1547474) =Intellectual Product =OCE Edit Code;
| - 1481. INT FIXATION-METACAR/CAR
- [ ] (UMLS (ICD9CM) C0187442) =Therapeutic or Preventive Procedure
|
- 1432. Insufficient Tissue
- (UMLS (HL7) C1547210) =Intellectual Product =Tissue Type Code;
| - 1482. INT FIXATION-METATAR/TAR
- [ ] (UMLS (ICD9CM) C0188844) =Therapeutic or Preventive Procedure
|
- 1433. INSUFFICNT PRENATAL CARE
- [ ] (UMLS (ICD9CM) C0695231) =Finding
| - 1483. INT FIXATION-RADIUS/ULNA
- [ ] (UMLS (ICD9CM) C0186901) =Therapeutic or Preventive Procedure
|
- 1434. Insufflation
- [Insufflation ( HL7V3.0 )] (UMLS (HL7) C0021634) =Health Care Activity =RouteByMethod;
| - 1484. INT FIXATION-TIBIA/FIBUL
- [ ] (UMLS (ICD9CM) C0188260) =Therapeutic or Preventive Procedure
|
- 1435. Insular Carcinoma
- [An adenocarcinoma arising from the thyroid gland showing only limited evidence of follicular cell differentiation. Microscopically, the adenocarcinoma cells are arranged in insular, solid, and trabecular patterns. There is associated necrosis, and vascular invasion. The prognosis depends on the tumor stage, complete or partial surgical removal of the tumor, and the degree of response to radioactive iodine therapy (adapted from WHO Tumors of Endocrine Organs, IARC Press, Lyon 2004) ( NCI )] (UMLS (NCI) C1266050) Poorly Differentiated Carcinoma of the Thyroid Gland;
Poorly Differentiated Carcinoma of Thyroid Gland;
Poorly Differentiated Thyroid Carcinoma;
Poorly Differentiated Thyroid Gland Carcinoma;
Thyroid Gland Poorly Differentiated Carcinoma;
=Neoplastic Process | - 1485. INT HEMORRHOID W/O COMPL
- [ ] (UMLS (ICD9CM) C0265035) =Disease or Syndrome ;
|
- 1436. Insular Pattern
- (UMLS (NCI) C1334188) =Finding ;
| - 1486. INT HEMRRHOID W COMP NEC
- [ ] (UMLS (ICD9CM) C0155782) =Acquired Abnormality ;
|
- 1437. Insulin Coma
- [Severe HYPOGLYCEMIA induced by a large dose of exogenous INSULIN resulting in a COMA or profound state of unconsciousness from which the individual cannot be aroused. ( MSH )] (UMLS (NCI) C0021645) =Disease or Syndrome =Blood Glucose, Low;
| - 1487. INT INF CLSTRDIUM DFCILE
- [ ] (UMLS (ICD9CM) C0494025) =Disease or Syndrome
|
- 1438. Insulin Detemir
- (UMLS (NCI) C0537270) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
| - 1488. INT INF E COLI ENTRHMRG
- (UMLS (ICD9CM) C0343381) =Disease or Syndrome
|
- 1439. Insulin Glulisine
- (UMLS (NCI) C1313386) Insulin, Glulisine, Human;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone | - 1489. INT INF E COLI ENTRNVSV
- (UMLS (ICD9CM) C0343382) =Disease or Syndrome
|
- 1440. INSULIN HUMAN
- (UMLS (NCI) C0795635) Insulin, Human;
INSULIN,REGULAR,HUMAN BUFFERED;
INSULIN,REGULAR,HUMAN BUFFERED PREPARATION;
INSULIN,REGULAR,HUMAN/rDNA;
INSULIN,REGULAR,HUMAN/rDNA PREPARATION;
INSULIN,REGULAR,HUMAN/SEMISYNTHETIC;
INSULIN,REGULAR,HUMAN/SEMISYNTHETIC PREPARATION;
Regular Insulin, Human =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone =[HS501] INSULIN;
Unclassified Ingredients =INSULIN,REGULAR,HUMAN BUFFERED 100 UNT/ML;
INSULIN,REGULAR,HUMAN/SEMISYNTHETIC 100 UNT/ML;
INSULIN,REGULAR,HUMAN/SEMISYNTHETIC 30 UNT/ML;
INSULIN,REGULAR,HUMAN/rDNA 100 UNT/ML;
INSULIN,REGULAR,HUMAN/rDNA 500 UNT/ML;
INSULIN,REGULAR,HUMAN/rDNA 30 UNT/ML;
INSULIN,REGULAR,HUMAN/rDNA 50 UNT/ML | - 1490. INT INF E COLI ENTRPATH
- (UMLS (ICD9CM) C0343380) =Disease or Syndrome
|
- 1441. insulin infusion system
- [Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor. ( MSH )] (UMLS (CSP) C0021648) =Medical Device
| - 1491. INT INF E COLI ENTRTOXGN
- (UMLS (ICD9CM) C0343379) =Disease or Syndrome
|
- 1442. insulin inhibitor
- [any substance or agent which suppresses, prevents or opposes the action of insulin. ( CSP )] (UMLS (CSP) C0021643) =Pharmacologic Substance =hormone antagonist;
| - 1492. INT INF E COLI SPCF NEC
- [ ] (UMLS (ICD9CM) C0494024) =Disease or Syndrome
|
- 1443. Insulin Pork
- (UMLS (NCI) C0770206) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
| - 1493. INT INF OTH GRM NEG BCTR
- (UMLS (ICD9CM) C0374932) =Disease or Syndrome
|
- 1444. insulin pump
- [An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner. The device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically. The device may also operate using a constant force to propel the fluid through a narrow tube which determines the flow rate. The device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm. ( SPN )] (UMLS (CSP) C1140609) =Medical Device
| - 1494. INT INF YRSNIA ENTRCLTCA
- (UMLS (ICD9CM) C0238528) =Disease or Syndrome
|
- 1445. INSULIN PUMP STATUS
- [ ] (UMLS (ICD9CM) C1260459) =Finding
| - 1495. INT THROMBOS HEMORRHOID
- [ ] (UMLS (ICD9CM) C0155781) =Acquired Abnormality; Disease or Syndrome
|
- 1446. Insulin Receptor Substrate 1
- [The protein IRS1 acts as an interface between signaling proteins with Src homology-2 domains (SH2 proteins) and the receptors for insulin, IGF2, growth hormone, several interleukins (IL4, IL9, IL13), and other cytokines. It regulates gene expression and stimulates mitogenesis and appears to mediate insulin/IGF1-stimulated glucose transport. (from OMIM 600797) ( NCI )] (UMLS (NCI) C0123658) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1496. INT-1 Related Protein
- [The WNT2 protein is a secreted growth factor member of the INT1 gene family and is associated with breast cancer. WNT2 is expressed in a variety of fetal and adult human tissues. (from OMIM 147870 and NCI) ( NCI )] (UMLS (NCI) C0123987) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 1447. Insulin Receptor Substrate 1 Gene
- [This gene plays a role in signal transduction and carbohydrate metabolism. It is involved in mediation of the insulin response. ( NCI )] (UMLS (NCI) C1334140) IRS1;
IRS1 Gene;
=Gene or Genome ;
◊ [This gene is involved in signal transduction and is associated with Diabetes Mellitus. ( NCI )] (UMLS (NCI) C1334141) IRS2; IRS2 Gene; Gene or Genome ; | - 1497. INT/COMB VERSION NO EXTR
- [ ] (UMLS (ICD9CM) C0195743) =Therapeutic or Preventive Procedure
|
- 1448. Insulin Receptor Substrate 2
- [Similar in function to IRS1; insulin receptor substrate 2 is a cytoplasmic protein that contains many potential tyrosine and serine/threonine phosphorylation sites. Tyrosine-phosphorylated IRS2 protein has been shown to associate with cytoplasmic signalling molecules that contain SH2 domains. The IRS2 protein is phosphorylated by the insulin receptor tyrosine kinase upon receptor stimulation, as well as by an interleukin-4 receptor (IL4R) -associated kinase in response to IL4 treatment. (LocusLink) ( NCI )] (UMLS (NCI) C1334191) IRS2;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 1498. INT/COMB VERSION W EXTR
- [ ] (UMLS (ICD9CM) C0195744) =Therapeutic or Preventive Procedure
|
- 1449. Insulin Receptor Substrate 4
- [Similar in function to IRS1 and IRS2; insulin receptor substrate 4 is a cytoplasmic protein that contains many potential tyrosine and serine/threonine phosphorylation sites. Tyrosine-phosphorylated IRS4 protein has been shown to associate with cytoplasmic signalling molecules that contain SH2 domains. The IRS4 protein is phosphorylated by the insulin receptor tyrosine kinase upon receptor stimulation. ( NCI )] (UMLS (NCI) C0664773) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1499. INT4
- [Encoded by human WNT3 Gene (WNT Family), 355-amino acid 39.6 kD (precursor) WNT-3 Protein is a wingless (Drosophila) homolog with 98% amino acid identity to mouse Wnt3 protein and 84% to human WNT3A protein. Highly-conserved structurally related WNT proteins are 350-400 amino acid, cysteine-rich, short-range putative paracrine signaling glycoprotein ligands for frizzled family seven transmembrane receptors involved in embryonic cell fate determination and patterning, as well as cell growth or differentiation in some adult mammalian tissues. Wnt3 is required in mouse primary axis formation and anterior-posterior neural patterning in the ectoderm. This protein may play a role in some cancers through activation of the WNT-beta-catenin-TCF signaling pathway. (from Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1504629) Wingless-Type MMTV Integration Site Family, Member 3 Protein;
WNT3;
WNT-3 Protein;
WNT-3 Proto-Oncogene Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 1450. Insulin Receptor Substrate 4 Gene
- [This gene plays a role in signal transduction and ligand binding. ( NCI )] (UMLS (NCI) C1334142) IRS4;
IRS4 Gene;
=Gene or Genome ;
| - 1500. Intact
- [Reproductively intact ( HL7V3.0 )] (UMLS (HL7) C1554187) =Idea or Concept =GenderStatus;
|
home
